SGLT2 Inhibitors Treatment Market - Top Companies and Manufacturers

Companies Dominating the SGLT2 Inhibitors Treatment Landscape

Novartis International AG

Company overview
Business strategy
Key product offerings
Financial performances
Key performance indicators
Risk analysis
Recent development
Regional presence
SWOT analysis

Boehringer Ingelheim GmbH
Janssen pharmaceuticals
GRUPO TECNIMEDE
Unichem Laboratories Ltd.
Edificio Bluepharma

Browse Key Market Insights with Data Illustration:

SGLT2 Inhibitors Treatment Market Size & Share, Growth Forecasts 2036

In the News

Astellas Pharma Inc., announced that selective SGLT2 inhibitor Suglat Tablets 25mg and 50mg Ipragliflozin L-Proline, “Suglat Tablets”) became available for the indication of type 2 diabetes in the Japanese market today.
AstraZeneca’s Forxiga (dapagliflozin) was approved in China to reduce the risk of cardiovascular (CV) death and hospitalization for heart failure in adults with heart failure (NYHA class II-IV) with reduced ejection fraction (HFrEF).

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of SGLT2 inhibitors treatment is estimated at USD 6.36 Billion.

The SGLT2 inhibitors treatment market size was over USD 5.86 Billion in 2023 and is likely to cross USD 19.06 Billion by the end of 2036, growing at more than 9.5% CAGR during the forecast period i.e., between 2024-2036. Growing Concern for the Prevalence of diabetes mellitus is estimated to boost the SGLT2 inhibitor treatment market.

North America industry is estimated to have the highest revenue share of 32% by 2036, impelled by increasing prevalence of obesity and lifestyle changes in the region.

Novartis International AG, Financial performancesBoehringer Ingelheim GmbH, Janssen pharmaceuticals, GRUPO TECNIMEDE, Unichem Laboratories Ltd., Edificio Bluepharma

SGLT2 Inhibitors Treatment Market - Top Companies and Manufacturers

Companies Dominating the SGLT2 Inhibitors Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the SGLT2 inhibitors treatment market?

Why is the SGLT2 inhibitors treatment sector gaining traction in near future?

Which region accounted for the largest SGLT2 inhibitors treatment industry share?

Who are the major SGLT2 inhibitors treatment players?